Ausgabe 4/2017
Inhalt (33 Artikel)
Did King Herod suffer from a rheumatic disease?
Cianna Leatherwood, Richard S. Panush
Bone regeneration in the stem cell era: safe play for the patient?
Estella Musacchio, Nicola Veronese
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry
Sara Monti, Catherine Klersy, Roberto Gorla, Piercarlo Sarzi-Puttini, Fabiola Atzeni, Raffaele Pellerito, Enrico Fusaro, Giuseppe Paolazzi, Pier Andrea Rocchetta, Ennio Giulio Favalli, Antonio Marchesoni, Roberto Caporali
Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing
Erin M. Scanlon, Rekha Mankad, Cynthia S. Crowson, Iftikhar J. Kullo, Sharon L. Mulvagh, Eric L. Matteson, Zoran Kvrgic, John M. Davis III
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
Florenzo Iannone, Delphine S. Courvoisier, Jacques Eric Gottenberg, Maria Victoria Hernandez, Elisabeth Lie, Helena Canhão, Karel Pavelka, Merete Lund Hetland, Carl Turesson, Xavier Mariette, Denis Choquette, Axel Finckh
Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab—a substudy of the optimized treatment algorithm in early RA (OPERA) trial
L. M. Ørnbjerg, M. Østergaard, T. Jensen, K. Hørslev-Petersen, K. Stengaard-Pedersen, P. Junker, T. Ellingsen, P. Ahlquist, H. Lindegaard, A. Linauskas, A. Schlemmer, M. Y. Dam, I. Hansen, T. Lottenburger, C. G. Ammitzbøll, A. Jørgensen, S. B. Krintel, J. Raun, M. L. Hetland, Ole Slot, Lars Kjær Nielsen, Henrik Skjødt, Ole Majgaard, Tove Lorenzen, Hans Christian Horn, Marcin Kowalski, Inger Lauge Johansen, Peter Mosborg Pedersen, Natalia Manilo, Henning Bliddal
Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritis
Ashley M. Hopkins, Michael D. Wiese, Catherine E. O’Doherty, Susanna M. Proudman
Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives?
Sonia Unriza-Puin, Wilson Bautista-Molano, Gloria I Lafaurie, Rafael Valle-Oñate, Philippe Chalem, Lorena Chila-Moreno, Juan Manuel Bello-Gualtero, Consuelo Romero-Sánchez
Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis
Ju-Hua Liu, Ming-Yen Ng, Tommy Cheung, Ho-Yin Chung, Yan Chen, Zhe Zhen, Yuan Zou, Ka-Fung Mak, Pek-Lan Khong, Chak-Sing Lau, Hung-Fat Tse, Kai-Hang Yiu
Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease
Yongfeng Zhang, Hongbin Li, Nawei Wu, Xin Dong, Yi Zheng
Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population
Xiao-Ke Yang, Peng Li, Song Li, Chao Zhang, Bao-Zhu Li, Rui-Xue Leng, Hai-Feng Pan, Dong-Qing Ye
APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus
Shideh Namazi, Nader Tajik, Vahid Ziaee, Maryam Sadr, Samaneh Soltani, Arezou Rezaei, Samaneh Zoghi, Nima Rezaei
Mannose-binding lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with systemic lupus erythematosus
Vir Singh Negi, Panneer Devaraju, Durga Prasanna Misra, Vikramraj K Jain, Jignesh Babulal Usdadiya, Paul T Antony, Reena Gulati
Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients
C. Reátegui-Sokolova, Manuel F. Ugarte-Gil, Rocío V. Gamboa-Cárdenas, Francisco Zevallos, Jorge M. Cucho-Venegas, José L Alfaro-Lozano, Mariela Medina, Zoila Rodriguez-Bellido, Cesar A. Pastor-Asurza, Graciela S. Alarcón, Risto A. Perich-Campos
Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis
Mahdi Mahmoudi, Faranak Fallahian, Soheila Sobhani, Shima Ghoroghi, Ahmadreza Jamshidi, Shiva Poursani, Masoumeh Dolati, Zahra Hosseinpour, Farhad Gharibdoost
Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis
Emmanouela Marou, Christos Liaskos, Theodora Simopoulou, Georgios Efthymiou, Efthymios Dardiotis, Christina Katsiari, Thomas Scheper, Wolfgang Meyer, Georgios Hadjigeorgiou, Dimitrios P. Bogdanos, Lazaros I. Sakkas
Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China
Yuqing Song, Chen Wang, Hong Chen
Psoriasis in systemic lupus erythematosus: a single-center experience
Konstantinos Tselios, Kristy Su-Ying Yap, Rattapol Pakchotanon, Ari Polachek, Jiandong Su, Murray B. Urowitz, Dafna D. Gladman
Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis
Georgia Barouta, Christina G. Katsiari, Ioannis Alexiou, Christos Liaskos, Areti Varna, Dimitrios P. Bogdanos, Anastasios E. Germenis, Lazaros I. Sakkas
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
Leslie R. Harrold, Bradley S. Stolshek, Sabrina Rebello, David H. Collier, Alex Mutebi, Sally W. Wade, Wendi Malley, Jeffrey D. Greenberg, Carol J. Etzel
Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis
L.G. Pelkmans, T.R. Hendriksz, P.J. Westenend, H.J. Vermeer, E.F.H. van Bommel
Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis
Hiroki Takeuchi, Teruaki Kawasaki, Kazuo Shigematsu, Kazuyuki Kawamura, Nobuyuki Oka
Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review
Violeta Higuera-Ortiz, Abraham Reynoso, Natllely Ruiz, Rosa Delia Delgado-Hernández, Gilberto Gómez-Garza, Luis Felipe Flores-Suárez
Circulating Dickkopf-1 and sclerostin in patients with Paget’s disease of bone
Luca Idolazzi, Angelo Fassio, Gaia Tripi, Vania Braga, Ombretta Viapiana, Giovanni Adami, Maurizio Rossini, Davide Gatti
Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density
Ben-Chung Cheng, Ying-Chou Chen
Comparing the accuracy and efficacy of ultrasound-guided versus blind injections of steroid in the glenohumeral joint in patients with shoulder adhesive capsulitis
Seyed Ahmad Raeissadat, Seyed Mansoor Rayegani, Taraneh Faghihi Langroudi, Maryam Khoiniha
Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors
Hiroki Wakabayashi, Hitoshi Inada, Yosuke Nishioka, Masahiro Hasegawa, Akihiro Sudo, Kusuki Nishioka
Ultrasound resistive index, power Doppler, and clinical parameters in established rheumatoid arthritis
Melissa Cláudia Bisi, Aline Defaveri do Prado, Deise Marcela Piovesan, Markus Bredemeier, Inês Guimarães da Silveira, José Alexandre de Mendonça, Henrique Luiz Staub
Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis
Ana M. Santos, Paola Peña, Mabel Avila, Ignacio Briceño, Carlos Jaramillo, Gilberto Vargas-Alarcon, Juan C. Rueda, Eugenia-Lucia Saldarriaga, Jose-Ignacio Angarita, Nancy Martinez-Rodriguez, John Londono
The effect of local injection of methylprednisolone acetate on the hypothalamic-pituitary-adrenal axis among patients with greater trochanteric pain syndrome
George Habib, Shada Elias, Muhanned Abu-Elhaija, Fahed Sakas, Fadi Khazin, Suheil Artul, Adel Jabbour, Haneen Jabaly-Habib
Muckle-Wells syndrome in Chinese patients: a single center case series
Di Wu, Min Shen
Recovery of nail dystrophy potential new therapeutic indication of tofacitinib
Jose A. Jaller, Juan J. Jaller, Antonio M. Jaller, Juan J. Jaller-Char, Sineida Berbert Ferreira, Rachel Ferreira, Morton Scheinberg
Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial
Manuel Martínez-Lavín